An excellent point. That would certainly be a point in Monsanto's favor. I am not sure I could say the same about the BRCA1 gene for breast cancer diagnosis though. That too is patented. Which reinforces for me how complex this issue is. We often discuss software patents (and as "practitioner of the art" :-) I can relate.) but I am not a biologist, much less a geneticist.
Yeah there are definitely points on each side. I wonder too how difficult this stuff is to skilled people, I wonder if there is a biohacker news where people laugh about the triviality of making something resistant to round up, like the triviality of 1 click purchasing.
I wish there was a biohacker news. While the idea is pretty trivial. Showing that it worked, getting it into plants and getting it to work well, and then getting the products through the pretty significant regulatory hurdles is not trivial.
